UMB Bank’s Bio-Rad Laboratories Class A BIO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $40.3K | Buy |
167
+79
| +90% | +$19.1K | ﹤0.01% | 1188 |
|
2025
Q1 | $21.4K | Sell |
88
-21
| -19% | -$5.12K | ﹤0.01% | 1306 |
|
2024
Q4 | $35.8K | Buy |
109
+32
| +42% | +$10.5K | ﹤0.01% | 1044 |
|
2024
Q3 | $25.8K | Buy |
77
+45
| +141% | +$15.1K | ﹤0.01% | 1114 |
|
2024
Q2 | $8.74K | Buy |
32
+31
| +3,100% | +$8.47K | ﹤0.01% | 1294 |
|
2024
Q1 | $346 | Buy |
+1
| New | +$346 | ﹤0.01% | 2060 |
|
2023
Q4 | – | Sell |
-9
| Closed | -$3.23K | – | 1619 |
|
2023
Q3 | $3.23K | Buy |
+9
| New | +$3.23K | ﹤0.01% | 1479 |
|
2023
Q1 | – | Sell |
-2
| Closed | -$1K | – | 1709 |
|
2022
Q4 | $1K | Sell |
2
-71
| -97% | -$35.5K | ﹤0.01% | 1597 |
|
2022
Q3 | $31K | Sell |
73
-16
| -18% | -$6.8K | ﹤0.01% | 979 |
|
2022
Q2 | $44K | Buy |
89
+16
| +22% | +$7.91K | ﹤0.01% | 946 |
|
2022
Q1 | $41K | Sell |
73
-76
| -51% | -$42.7K | ﹤0.01% | 1020 |
|
2021
Q4 | $113K | Buy |
+149
| New | +$113K | ﹤0.01% | 783 |
|